tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shanghai Haohai Biological Technology Schedules Board Meeting for Annual Results

Story Highlights
Shanghai Haohai Biological Technology Schedules Board Meeting for Annual Results

Elevate Your Investing Strategy:

An update from Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) is now available.

Shanghai Haohai Biological Technology Co., Ltd. has scheduled a board meeting for March 21, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend, which could impact the company’s financial strategy and shareholder returns.

More about Shanghai Haohai Biological Technology Co., Ltd. Class H

Shanghai Haohai Biological Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the biotechnology sector, focusing on the development and production of biological products.

YTD Price Performance: -0.56%

Average Trading Volume: 254,896

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$13.49B

For detailed information about 6826 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1